Conning Inc. Boston Scientific Corp Transaction History

Conning Inc.

$2.8 Billion
Q3 2025

A detailed history of Conning Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Conning Inc. holds 9,130 shares of BSX stock, worth $937,559. This represents 0.03% of its overall portfolio holdings.

Number of Shares

9,130

Previous 9,130 -0.0%

Holding current value

$937,559

Previous $980,000 9.08%

% of portfolio

0.03%

Previous 0.04%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$89.7 - $107.41 $22,783 - $27,282	-254 Reduced 2.71%	9,130 $980,000
Q1 2025 Apr 28, 2025	BUY	$89.38 - $106.18 $804 - $955	9 Added 0.1%	9,384 $946,000
Q4 2024 Jan 28, 2025	SELL	$83.62 - $91.5 $106,448 - $116,479	-1,273 Reduced 11.96%	9,375 $837,000
Q3 2024 Oct 29, 2024	SELL	$72.96 - $84.0 $8,098 - $9,324	-111 Reduced 1.03%	10,648 $892,000
Q2 2024 Jul 26, 2024	BUY	$67.33 - $77.71 $27,739 - $32,016	412 Added 3.98%	10,759 $828,000
Q1 2024 Apr 26, 2024	SELL	$57.6 - $68.62 $13,824 - $16,468	-240 Reduced 2.27%	10,347 $708,000
Q4 2023 Jan 29, 2024	BUY	$48.64 - $57.81 $3,161 - $3,757	65 Added 0.62%	10,587 $612,000
Q3 2023 Oct 26, 2023	SELL	$50.19 - $54.68 $7,026 - $7,655	-140 Reduced 1.31%	10,522 $555,000
Q2 2023 Jul 21, 2023	SELL	$49.72 - $54.64 $74,580 - $81,960	-1,500 Reduced 12.33%	10,662 $576,000
Q1 2023 Apr 27, 2023	SELL	$45.09 - $50.03 $3,111 - $3,452	-69 Reduced 0.56%	12,162 $608,000
Q4 2022 Feb 07, 2023	SELL	$39.56 - $47.22 $1,068 - $1,274	-27 Reduced 0.22%	12,231 $566,000
Q3 2022 Oct 28, 2022	SELL	$36.71 - $109.66 $106,202 - $317,246	-2,893 Reduced 19.09%	12,258 $475,000
Q2 2022 Jul 20, 2022	SELL	$35.24 - $47.1 $4,017 - $5,369	-114 Reduced 0.75%	15,151 $565,000
Q1 2022 May 02, 2022	BUY	$40.9 - $45.1 $15,542 - $17,138	380 Added 2.55%	15,265 $676,000
Q4 2021 Jan 27, 2022	BUY	$38.07 - $44.87 $69,858 - $82,336	1,835 Added 14.06%	14,885 $632,000
Q3 2021 Nov 05, 2021	SELL	$41.23 - $45.88 $177,247 - $197,238	-4,299 Reduced 24.78%	13,050 $566,000
Q2 2021 Jul 29, 2021	SELL	$38.58 - $44.24 $64,891 - $74,411	-1,682 Reduced 8.84%	17,349 $742,000
Q1 2021 Apr 23, 2021	SELL	$35.27 - $39.67 $60,311 - $67,835	-1,710 Reduced 8.24%	19,031 $736,000
Q4 2020 Jan 28, 2021	SELL	$33.15 - $41.97 $13,889 - $17,585	-419 Reduced 1.98%	20,741 $746,000
Q3 2020 Oct 21, 2020	BUY	$34.44 - $42.23 $13,431 - $16,469	390 Added 1.88%	21,160 $809,000
Q2 2020 Aug 07, 2020	BUY	$30.19 - $39.11 $37,979 - $49,200	1,258 Added 6.45%	20,770 $729,000
Q1 2020 Apr 29, 2020	SELL	$25.83 - $45.71 $13,612 - $24,089	-527 Reduced 2.63%	19,512 $637,000
Q4 2019 Jan 29, 2020	SELL	$37.87 - $45.37 $30,295 - $36,296	-800 Reduced 3.84%	20,039 $906,000
Q3 2019 Oct 30, 2019	SELL	$40.31 - $43.45 $98,719 - $106,409	-2,449 Reduced 10.52%	20,839 $848,000
Q2 2019 Jul 25, 2019	SELL	$34.91 - $42.98 $123,232 - $151,719	-3,530 Reduced 13.16%	23,288 $1 Million
Q1 2019 Apr 22, 2019	BUY	$32.91 - $40.75 $4,278 - $5,297	130 Added 0.49%	26,818 $1.03 Million
Q4 2018 Jan 29, 2019	SELL	$31.73 - $39.04 $87,574 - $107,750	-2,760 Reduced 9.37%	26,688 $943,000
Q3 2018 Oct 26, 2018	SELL	$32.83 - $38.63 $59,520 - $70,036	-1,813 Reduced 5.8%	29,448 $1.13 Million
Q2 2018 Jul 25, 2018	SELL	$26.84 - $34.32 $30,060 - $38,438	-1,120 Reduced 3.46%	31,261 $1.02 Million
Q1 2018 May 04, 2018	BUY	$25.2 - $28.54 $756 - $856	30 Added 0.09%	32,381 $885,000
Q4 2017 Jan 30, 2018	SELL	$24.79 - $29.8 $18,840 - $22,648	-760 Reduced 2.3%	32,351 $802,000
Q3 2017 Oct 20, 2017	BUY	$26.26 - $29.17 $869,494 - $965,847	33,111	33,111 $966,000

Others Institutions Holding BSX

# of Institutions

1,952

Shares Held

1.26B

Call Options Held

10.9M

Put Options Held

8.94M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $147B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conning Inc. with notifications on news.

Account